Medication info
Amaryl Tablets 4 mg (Glimepiride)

Amaryl Tablets 4 mg (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
(Hanmi Pharmaceutical Co., Ltd.)
Appearance
Light blue rectangular tablets.
Packaging
30 tablets (10 tablets/PTP X 3). 100 tablets/bottle
Approval status
Active

MFDS item code 199900923 · Notified 1999.11.15 · Insurance code 652100820

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose should be adjusted individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the instructions under Initial dose. That is, treatment may be initiated at 1 mg once daily, with dose adjustment at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be taken into account. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. With combination therapy of this medicine and metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
(Hanmi Pharmaceutical Co., Ltd.)

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with Type 2 diabetes. It can also be used alone and can enhance blood sugar control when combined with other medications. It provides positive assistance in managing blood sugar for patients, improving overall blood sugar regulation.

How to take

Adult dose

The dose should be adjusted individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If needed, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg once daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the instructions under Initial dose. That is, treatment may be initiated at 1 mg once daily, with dose adjustment at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be taken into account. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. With combination therapy of this medicine and metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent Type 1 diabetes, diabetic ketoacidosis, or those in a coma. It is also advisable not to administer this medication to patients who are allergic to this drug or its ingredients, or who have severe liver or kidney dysfunction. It is safest for pregnant women or women who may become pregnant, as well as nursing mothers, to avoid this medication and consider insulin treatment instead. Insulin therapy is recommended for patients with severe infections, pre- and post-surgical conditions, or severe trauma. Caution is advised for patients with gastrointestinal disturbances, as this may inhibit food absorption and increase the risk of hypoglycemia. Patients with lactose intolerance or specific genetic metabolic disorders should not take this medication. In the early stages of treatment, there is a higher risk of hypoglycemia, so close monitoring of blood sugar levels is essential. Elderly patients, those with poor nutritional status or irregular eating patterns, patients with impaired kidney or liver function, and individuals who consume alcohol frequently are at higher risk for hypoglycemia. Patients with thyroid or adrenal dysfunction should also be cautious. Symptoms of hypoglycemia may include headaches, severe hunger, vomiting, fatigue, anxiety, confusion, drowsiness, and decreased consciousness; if these symptoms appear, immediate consumption of sugar is necessary. This medication may interact with various drugs that can affect blood sugar control, so it is important to inform healthcare providers if taking other medications, especially beta-blockers, some antibiotics, anti-inflammatory drugs, or steroids. Pregnant or nursing women are advised to consider insulin treatment due to potential effects on the fetus and newborn. The safety and efficacy of this medication have not been established in children under 18 years of age. The elderly may require dose adjustments due to decreased kidney function slowing drug elimination. In cases of overdose, severe hypoglycemia may occur, warranting immediate medical attention for appropriate emergency treatment. This medication should be stored out of reach of children and kept securely sealed in its original container.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, speech disturbances, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, lethargy, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, venous arrhythmia, blurred vision, feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, indigestion, facial swelling, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This practice helps preserve the medication's effectiveness and safety.

Appearance and packaging

Appearance

Light blue rectangular tablets.

Package unit

30 tablets (10 tablets/PTP X 3). 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.